The China Mail - Who should get paid for nature's sequenced genes?

USD -
AED 3.672503
AFN 63.999633
ALL 81.13116
AMD 364.066319
ANG 1.790365
AOA 917.999554
ARS 1524.997501
AUD 1.439429
AWG 1.8025
AZN 1.699887
BAM 1.725719
BBD 2.018882
BDT 123.247965
BGN 1.683441
BHD 0.377906
BIF 3005.722202
BMD 1
BND 1.279885
BOB 12.063778
BRL 5.184055
BSD 1.002338
BTN 96.076978
BWP 14.120969
BYN 3.01672
BYR 19600
BZD 2.01597
CAD 1.42459
CDF 2310.000003
CHF 0.836205
CLF 0.024656
CLP 973.539878
CNY 6.70475
CNH 6.71436
COP 3314.79
CRC 457.846208
CUC 1
CUP 24.056893
CVE 97.29465
CZK 21.580966
DJF 178.497375
DKK 6.601103
DOP 59.602065
DZD 133.919964
EGP 51.941199
ERN 15
ETB 163.729916
EUR 0.88295
FJD 2.24875
FKP 0.756991
GBP 0.75445
GEL 2.60498
GGP 0.756991
GHS 11.732889
GIP 0.756991
GMD 74.000372
GNF 8750.000468
GTQ 7.658099
GYD 209.730789
HKD 7.84665
HNL 26.909604
HRK 6.6528
HTG 131.186306
HUF 323.419643
IDR 17937
ILS 3.07365
IMP 0.756991
INR 95.96915
IQD 1313.138889
IRR 1693792.502544
ISK 120.969796
JEP 0.756991
JMD 158.635902
JOD 0.708994
JPY 158.143502
KES 129.719972
KGS 87.4487
KHR 4065.101628
KMF 435.000056
KPW 900.000318
KRW 1360.175049
KWD 0.30903
KYD 0.835337
KZT 440.918897
LAK 22497.408184
LBP 89762.385847
LKR 331.231884
LRD 171.912363
LSL 16.416191
LTL 2.95274
LVL 0.60489
LYD 6.411082
MAD 9.723465
MDL 17.796797
MGA 4402.876428
MKD 54.331282
MMK 2099.600314
MNT 3599.1704
MOP 8.102072
MRU 40.144704
MUR 47.75987
MVR 15.449965
MWK 1738.121498
MXN 18.08776
MYR 4.086498
MZN 63.909596
NAD 16.41706
NGN 1326.860227
NIO 36.892099
NOK 9.633325
NPR 153.717739
NZD 1.77802
OMR 0.384505
PAB 1.002374
PEN 3.450819
PGK 4.536992
PHP 62.741981
PKR 277.681916
PLN 3.85205
PYG 5864.031411
QAR 3.65434
RON 4.657014
RSD 103.796978
RUB 83.375041
RWF 1480.037058
SAR 3.759293
SBD 8.032647
SCR 13.836223
SDG 601.505977
SEK 10.01845
SGD 1.27922
SHP 0.755829
SLE 24.649875
SLL 20969.491881
SOS 572.815106
SRD 37.621502
STD 20697.981008
STN 21.617329
SVC 8.77073
SYP 13002.000254
SZL 16.407994
THB 33.620498
TJS 9.232161
TMT 3.51
TND 2.97262
TOP 2.40776
TRY 49.032203
TTD 6.800164
TWD 31.937496
TZS 2640.002984
UAH 44.775489
UGX 3929.198542
UYU 40.386126
UZS 11858.028368
VES 857.98905
VND 25966
VUV 119.008285
WST 2.76852
XAF 579.17706
XAG 0.016353
XAU 0.000240041575
XCD 2.70255
XCG 1.806559
XDR 0.707052
XOF 579.17706
XPF 105.230186
YER 236.396786
ZAR 16.44243
ZMK 9001.20083
ZMW 19.596771
ZWL 321.999592
SSP 5712.591896
MXV 2.047495
  • RYCEF

    0.4000

    19.71

    +2.03%

  • CMSC

    0.0000

    20.4

    0%

  • BTI

    0.4200

    56.05

    +0.75%

  • BP

    0.2800

    44.43

    +0.63%

  • RBGPF

    1.6000

    67

    +2.39%

  • RIO

    -0.1500

    94.41

    -0.16%

  • AZN

    -0.4300

    166.15

    -0.26%

  • GSK

    0.4600

    49.7

    +0.93%

  • BCE

    -0.4100

    20.56

    -1.99%

  • NGG

    -0.2500

    75.24

    -0.33%

  • VOD

    -0.0400

    16.58

    -0.24%

  • RELX

    -0.4500

    33.07

    -1.36%

  • BCC

    -0.5500

    76.59

    -0.72%

  • CMSD

    -0.0300

    20.27

    -0.15%

  • JRI

    -0.2500

    10.77

    -2.32%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Su--ThChM